Potential long-term effects of MDMA on the basal ganglia-thalamocortical circuit: A proton MR spectroscopy and diffusion-tensor imaging study

Radiology

Volumn 260, Issue 2, 2011, Pages 531-540

  Liu, Hua Shan ^a,b   Chou, Ming Chung ^c   Chung, Hsiao Wen ^a,b   Cho, Nai Yu ^a,d   Chiang, Shih Wei ^a   Wang, Chao Ying ^a   Kao, Hung Wen ^a   Huang, Guo Shu ^a   Chen, Chen Yu ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CHOLINE; INOSITOL;

ADULT; ANATOMICAL VARIATION; ARTICLE; BASAL GANGLION; BRAIN FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DRUG ABUSE; DRUG EFFICACY; ELECTROENCEPHALOGRAM; FEMALE; FRACTIONAL ANISOTROPY; FRONTAL CORTEX; GLIA; HUMAN; IMAGE PROCESSING; MALE; METABOLIC INHIBITION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SEROTONINERGIC SYSTEM; THALAMOCORTICAL TRACT;

ADOLESCENT; ADULT; ANISOTROPY; ASPARTIC ACID; BASAL GANGLIA; BRAIN MAPPING; CEREBRAL CORTEX; CHOLINE; CREATINE; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PHOSPHOCREATINE; STATISTICS, NONPARAMETRIC; THALAMUS;

EID: 79960679862     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11101918     Document Type: Article

References (31)

1. Ricaurte GA, Martello AL, Katz JL, Martello MB. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. J Pharmacol Exp Ther 1992;261(2):616-622.
2. McGregor IS, Clemens KJ, Van der Plasse G, et al. Increased anxiety 3 months after brief exposure to MDMA ("ecstasy") in rats: association with altered 5-HT transporter and receptor density. Neuropsychopharmacology 2003;28(8):1472-1484. (Pubitemid 41070882)
3. Schmued LC. Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA. Brain Res 2003;974(1-2):127-133. (Pubitemid 36549226)
4. Karageorgiou J, Dietrich MS, Charboneau EJ, et al. Prior MDMA (ecstasy) use is associated with increased basal ganglia-thalamocortical circuit activation during motor task performance in humans: an fMRI study. Neuroimage 2009;46(3):817-826.
5. Wilson MA, Ricaurte GA, Molliver ME. Distinct morphologic classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3,4-methylenedioxymethamphetamine. Neuroscience 1989;28(1):121-137. (Pubitemid 19026748)
6. Nakamura K, Matsumoto M, Hikosaka O. Reward-dependent modulation of neuronal activity in the primate dorsal raphe nucleus. J Neurosci 2008;28(20):5331-5343.
7. Alexander GE, Crutcher MD, DeLong MR. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res 1990;85:119-146.
8. Obrocki J, Schmoldt A, Buchert R, Andresen B, Petersen K, Thomasius R. Specific neurotoxicity of chronic use of ecstasy. Toxicol Lett 2002;127(1-3):285-297. (Pubitemid 34615520)
9. Ernst T, Chang L, Jovicich J, Ames N, Arnold S. Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients. Neurology 2002;59(9):1343-1349. (Pubitemid 35285984)
10. Moeller FG, Steinberg JL, Dougherty DM, Narayana PA, Kramer LA, Renshaw PF. Functional MRI study of working memory in MDMA users. Psychopharmacology (Berl) 2004;177(1-2):185-194. (Pubitemid 40109929)
11. Reneman L, Majoie CB, Habraken JB, den Heeten GJ. Effects of ecstasy (MDMA) on the brain in abstinent users: initial observations with diffusion and perfusion MR imaging. Radiology 2001;220(3):611-617. (Pubitemid 32799965)
12. de Win MM, Jager G, Booij J, et al. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain 2008;131(Pt 11):2936-2945.
13. Burruss JW, Hurley RA, Taber KH, Rauch RA, Norton RE, Hayman LA. Functional neuroanatomy of the frontal lobe circuits. Radiology 2000;214(1):227-230.
14. Chang L, Ernst T, Grob CS, Poland RE. Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy") users. J Magn Reson Imaging 1999;10(4):521-526.
15. Takao H, Abe O, Yamasue H, Aoki S, Kasai K, Ohtomo K. Cerebral asymmetry in patients with schizophrenia: a voxel-based morphometry (VBM) and diffusion tensor imaging (DTI) study. J Magn Reson Imaging 2010;31(1):221-226.
16. McClelland JL, Siegler RS. Mechanisms of cognitive development: behavioral and neural perspectives. Mahwah, NJ: Lawrence Erlbaum Associates, 2001.
17. First M, Spitzer R, Gibbon M, Williams J. Structured clinical interview for DSM-IV axis I disorders (SCID-I). Washington, DC: American Psychiatric Press, 1997.
18. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30(6):672-679. (Pubitemid 23360802)
19. Zhilkin P, Alexander ME. Affine registration: a comparison of several programs. Magn Reson Imaging 2004;22(1):55-66. (Pubitemid 38221584)
20. Mori S, Oishi K, Jiang H, et al. Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template. Neuroimage 2008;40(2):570-582.
21. Vercauteren T, Pennec X, Perchant A, Ayache N. Diffeomorphic demons: efficient nonparametric image registration. Neuroimage 2009;45 (s uppl 1):S61-S72.
22. Chou MC, Wang CY, Liu HS, Chung HW, Chen CY. Pseudolesions arising from unfolding artifacts in diffusion imaging with use of parallel acquisition: origin and remedies. AJNR Am J Neuroradiol 2007;28(6):1099-1101.
23. Moeller FG, Steinberg JL, Lane SD, et al. Diffusion tensor imaging in MDMA users and controls: association with decision making. Am J Drug Alcohol Abuse 2007;33(6):777-789. (Pubitemid 350125770)
24. Cowan RL. Neuroimaging research in human MDMA users: a review. Psychopharmacology (Berl) 2007;189(4):539-556. (Pubitemid 44791223)
25. Cowan RL, Bolo NR, Dietrich M, Haga E, Lukas SE, Renshaw PF. Occipital cortical proton MRS at 4 Tesla in human moderate MDMA polydrug users. Psychiatry Res 2007;155(3):179-188. (Pubitemid 47042362)
26. Daumann J, Fischermann T, Pilatus U, Thron A, Moeller-Hartmann W, Gouzoulis- Mayfrank E. Proton magnetic resonance spectroscopy in ecstasy (MDMA) users. Neurosci Lett 2004;362(2):113-116. (Pubitemid 38759080)
27. Reneman L, Majoie CB, Flick H, den Heeten GJ. Reduced N -acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (ecstasy) users: preliminary results. AJNR Am J Neuroradiol 2002;23(2):231-237. (Pubitemid 34160428)
28. de Win MM, Reneman L, Jager G, et al. A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users. Neuropsychopharmacology 2007;32(2):458-470. (Pubitemid 46106952)
29. Benveniste H, Hedlund LW, Johnson GA. Mechanism of detection of acute cerebral ischemia in rats by diffusion-weighted magnetic resonance microscopy. Stroke 1992;23(5):746-754.
30. Herrero MT, Barcia C, Navarro JM. Functional anatomy of thalamus and basal ganglia. Childs Nerv Syst 2002;18(8):386-404. (Pubitemid 36013686)
31. Mandl RC, Schnack HG, Zwiers MP, van der Schaaf A, Kahn RS, Hulshoff Pol HE. Functional diffusion tensor imaging: measuring task-related fractional anisotropy changes in the human brain along white matter tracts. PLoS ONE 2008;3(11):e3631.